Advertisement

Topics

Top Pharmaceutical Companies in Asia

00:33 EDT 22nd September 2017 | BioPortfolio

 

Company Rank 2014 (2013) Country 2013 pharma sales ($)2014 2012 pharma sales ($m)2013 Change from 2013 Notes
Takeda 1 (1) Japan 15294 15694 -3%  
Astellas 2 (2) Japan 11815 11700 1%  
Daiichi Sankyo 3 (3) Japan 8709 10990 -21% Ranbaxy sale removed approximately $1.5bn
Otsuka Pharmaceutical 4 (4) Japan 8369 10624 -21% 9 months data: FY changed
CSL 5 (6) Australia 5335 4791 11% FY ends June 2014
Eisai 6 (5) Japan 5196 6162 -16%  
Sun Pharmaceutical 7 (11) India 4474 2643 69% Acquired Ranbaxy
Dainippon Sumitomo Pharma 8 (8) Japan 3518 3549 -1%  
Mitsubishi Tanabe Pharma 9 (7) Japan 3287 3747 -12% Ethical drugs
Shionogi 10 (9) Japan 2596 2974 -13%  
Kyowa Hakko Kirin 11 (10) Japan 2397 2679 -11%  
Dr Reddy's 12 (12) India 1977 1805 10% Global Generics only
Lupin 13 (13) India 1870 1713 9% Excludes 'Finished dosage' and APIs
Cipla 14 (14) India 1784 1674 7%  
Zhejinag Hisun Pharma 15 (21) China 1608 1368 18%  
Hisamitsu 16 (16) Japan 1485 1546 -4%  
Teijin Pharma 17 (19) Japan 1342 1421 -6%  
Meiji Holdings 18 (20) Japan 1339 1387 -3%  
Santen Pharmaceutical 19 (17) Japan 1289 1526 -16%  
Ono Pharmaceutical 20 (18) Japan 1286 1470 -13%  
Cadila 21 (22) India 1156 1242 -7%  
Taisho Pharmaceutical 22 (23) Japan 1082 1172 -8%  
Glenmark Pharmaceuticals 23 (26) India 1081 1021 6%  
Kyorin 24 (24) Japan 1072 1143 -6%  
Sawai Pharmaceutical 25 (28) Japan 999 922 8%  
Yuhan Pharma 26 (30) South Korea 967 862 12% Total sales, may include API
Green Cross 27 (32) South Korea 927 812 14%  
Kaken Pharmaceutical 28 (29) Japan 889 913 -3%  
China Pharmaceutical Group 29 (33) Hong Kong 866 750 15% Finished drugs' segment
Shanghai Pharmaceutical 30 (25) China 828 1039 -20%  
Mochida Pharmaceutical 31 (27) Japan 827 964 -14%  
Asahi Kasei 32 (15) Japan 764 1566 -51% Company projection: 2014 data not released
Torrent Pharmaceuticals 33 (34) India 763 713 7%  
Wockhardt 34 (31) India 735 829 -11%  
Hanmi Pharm 35 (35) South Korea 723 667 8%  
Daewoong Pharmaceutical 36 (42) South Korea 699 617 13%  
Towa Pharmaceutical 37 (41) Japan 677 630 8%  
Maruho 38 (39) Japan 644 648 -1%  
CK Life Sciences 39 (40) Hong Kong 639 641 0% Total sales, not pharma-specific
Kissei 40 (36) Japan 625 667 -6%  
Nippon Shinyaku 41 (38) Japan 596 650 -8%  
Japan Tobacco 42 (37) Japan 550 665 -17%  
Toray Industries 43 (43) Japan 540 597 -10%  
Dong-A ST 44 (50) South Korea 540 452 19%  
Chong Kun Dang 45 (46) South Korea 517 512 1%  
Hutchison China MediTech 46 (53) Hong Kong 509 395 29% China Healthcare division subsidiaries and JVs
JEIL Pharmaceutical 47 (51) South Korea 487 413 18%  
Nippon Kayaku 48 (45) Japan 464 522 -11%  
Kaneka 49 (48) Japan 449 487 -8% Life Science Products sales, may inclue API and devices
Jubilant Life Sciences 50 (49) India 440 469 -6% Pharma Segment
Aska Pharmaceutical 51 (47) Japan 406 495 -18%  
LG Life Sciences 52 (64) South Korea 404 305 32% Pharma sales estimated for 2013
Ildong 53 (55) South Korea 397 376 5%  
JW Pharmaceutical Corporation 54 (58) South Korea 392 361 9%  
Ajinomoto 55 (44) Japan 376 523 -28% Pharma sales fell due to divestment of infusion and dialysis business
Biocon 56 (56) India 367 369 -1% Unaudited: full results expected July
Maruishi Pharmaceutical 57 (52) Japan 349 395 -12%  
Zeria Pharmaceuticals 58 (54) Japan 347 380 -9% Estimated for 2013
Boryung 59 (66) South Korea 342 299 14%  
Alembic 60 (62) India 337 320 5%  
Handok 61 (65) South Korea 331 300 10%  
Simcere Pharmaceutical 62 (60) China 328 328 0% 2013 data: Simcere taken private in 2013
Nippon Chemiphar 63 (63) Japan 324 316 2%  
Senju Pharmaceutical 64 (59) Japan 315 339 -7%  
Yakult Honsha 65 (57) Japan 308 363 -15%  
Orchid Pharmaceuticals 66 (61) India 281 326 -14% 18 months ending March 2015 vs previous 18 months
Seikagaku 67 (67) Japan 280 260 8%  
Shin Poong 68 (70) South Korea 209 197 6%  
Dong Wha 69 (69) South Korea 203 201 1%  
Strides Arcolab 70 (68) India 196 231 -15%  
Samjin Pharmaceutical 71 (71) South Korea 191 173 11%  
Beximco Pharmaceuticals 72 (73) Bangladesh 144 135 7%  
Il-Yang 73 (72) South Korea 140 135 4%  
Bukwang 74 (74) South Korea 134 128 5%  
Piramal Healthcare 75 (75) India 124 124 0% Critical Care division
Panacea Biotec 76 (78) India 107 84 27%  
Kureha 77 (77) Japan 94 98 -4%  
Nissan Chemical 78 (76) Japan 83 119 -30%  
Hyundai Pharm 79 (80) South Korea 67 64 6% 85% of revenue is pharma, and 77% of that is prescription drugs
Sinovac Biotech 80 (79) China 63 73 -13%  
Il Sung Pharmaceuticals 81 (81) South Korea 60 57 4%  
Sosei 82 (82) Japan 35 21 64% Acquired Jitsubo and Heptares Therapeutics

Source: http://www.scrip100.com/asia/

Quick Search
Advertisement
 

review and buy Top Pharmaceutical Companies in Asia market research data and corporate reports here